Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a diabetes drug boost psoriasis treatment? new trial investigates

NCT ID NCT07485764

Not yet recruiting Disease control Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Apr 06, 2026 · Last updated May 09, 2026 · Updated 5 times

Summary

This study tests whether adding metformin (a diabetes drug) to secukinumab (a standard psoriasis medication) works better than secukinumab alone for treating moderate-to-severe plaque psoriasis in overweight or obese Chinese adults. About 186 participants will receive either the combination or secukinumab plus a placebo. The main goal is to see if more people achieve clear or almost clear skin after 24 weeks. The trial lasts 60 weeks and also checks quality of life and safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MODERATE TO SEVERE PLAQUE PSORIASIS OVERWEIGHT , OBESITY PLAQUE PSORIASIS PSORIASIS